Strategic Blueprint LLC Raises Stock Position in Astera Labs, Inc. $ALAB

Key Points

• Strategic Blueprint LLC increased its holdings in Astera Labs by 68.9% in Q2, owning a total of 7,308 shares worth approximately $661,000 at the end of the quarter.
• Astera Labs received mixed ratings from analysts, with a consensus rating of "Moderate Buy" and an average price target of $162.06.
• The company's recent earnings report showed a 149.5% year-over-year increase in quarterly revenue, reaching $191.93 million with an EPS of $0.44.

Strategic Blueprint LLC grew its holdings in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 68.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,308 shares of the company's stock after acquiring an additional 2,981 shares during the period. Strategic Blueprint LLC's holdings in Astera Labs were worth $661,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the business. Vanguard Group Inc. boosted its holdings in shares of Astera Labs by 0.9% in the 1st quarter. Vanguard Group Inc. now owns 9,297,476 shares of the company's stock valued at $554,780,000 after acquiring an additional 85,846 shares during the last quarter. Alliancebernstein L.P. lifted its stake in shares of Astera Labs by 114.2% in the 1st quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company's stock valued at $501,289,000 after purchasing an additional 4,478,741 shares during the period. Atreides Management LP lifted its stake in shares of Astera Labs by 153.3% in the 1st quarter. Atreides Management LP now owns 4,652,264 shares of the company's stock valued at $277,601,000 after purchasing an additional 2,815,614 shares during the period. Fred Alger Management LLC lifted its stake in shares of Astera Labs by 13.0% in the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company's stock valued at $93,087,000 after purchasing an additional 179,638 shares during the period. Finally, FengHe Fund Management Pte. Ltd. acquired a new position in shares of Astera Labs in the 2nd quarter valued at $106,772,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ALAB has been the subject of several analyst reports. Bank of America initiated coverage on shares of Astera Labs in a research note on Friday, October 3rd. They issued a "neutral" rating and a $230.00 target price for the company. Zacks Research cut shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research note on Monday, October 6th. Northland Capmk cut shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, July 22nd. Evercore ISI upped their price objective on shares of Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 6th. Finally, TD Cowen initiated coverage on shares of Astera Labs in a research report on Wednesday, October 1st. They set a "hold" rating and a $200.00 price objective for the company. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $162.06.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $164.97 on Friday. The company has a fifty day moving average of $196.79 and a two-hundred day moving average of $131.95. The stock has a market capitalization of $27.42 billion, a PE ratio of 294.59, a P/E/G ratio of 4.11 and a beta of 1.43. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. The business had revenue of $191.93 million during the quarter, compared to analysts' expectations of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company's quarterly revenue was up 149.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.13 earnings per share. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Research analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insiders Place Their Bets

In other news, CFO Michael Truett Tate sold 18,861 shares of the stock in a transaction dated Monday, August 18th. The shares were sold at an average price of $183.51, for a total value of $3,461,182.11. Following the completion of the sale, the chief financial officer directly owned 259,512 shares in the company, valued at $47,623,047.12. This represents a 6.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Jack R. Lazar sold 22,500 shares of the stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $178.42, for a total transaction of $4,014,450.00. Following the completion of the sale, the director owned 97,351 shares of the company's stock, valued at $17,369,365.42. This trade represents a 18.77% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,092,997 shares of company stock valued at $192,231,120. Corporate insiders own 12.50% of the company's stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.